{"_id":"YotM3X8RQ3NpdH9wH","bibbaseid":"anonymous-drugdiscoverystrategiesandthepreclinicaldevelopmentofdaminoacidoxidaseinhibitorsasantipsychotictherapiesexpertopinionondrugdiscoveryvol13no10-2020","bibdata":{"bibtype":"misc","type":"misc","title":"Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies: Expert Opinion on Drug Discovery: Vol 13, No 10","url":"https://www.tandfonline.com/doi/abs/10.1080/17460441.2018.1524459","urldate":"2020-08-18","month":"August","year":"2020","bibtex":"@misc{noauthor_drug_2020,\n\ttitle = {Drug discovery strategies and the preclinical development of {D}-amino-acid oxidase inhibitors as antipsychotic therapies: {Expert} {Opinion} on {Drug} {Discovery}: {Vol} 13, {No} 10},\n\turl = {https://www.tandfonline.com/doi/abs/10.1080/17460441.2018.1524459},\n\turldate = {2020-08-18},\n\tmonth = aug,\n\tyear = {2020},\n}\n\n","key":"noauthor_drug_2020","id":"noauthor_drug_2020","bibbaseid":"anonymous-drugdiscoverystrategiesandthepreclinicaldevelopmentofdaminoacidoxidaseinhibitorsasantipsychotictherapiesexpertopinionondrugdiscoveryvol13no10-2020","role":"","urls":{"Paper":"https://www.tandfonline.com/doi/abs/10.1080/17460441.2018.1524459"},"metadata":{"authorlinks":{}}},"bibtype":"misc","biburl":"https://api.zotero.org/users/6447874/collections/MNC693EY/items?key=EzirEtCHddAI8OiL0hFklGbe&format=bibtex&limit=100","dataSources":["oifZ6kNaBgC8TKSa7","eTsH756eicg6vxuG3","b5dAwZGGHrrN9aGTK"],"keywords":[],"search_terms":["drug","discovery","strategies","preclinical","development","amino","acid","oxidase","inhibitors","antipsychotic","therapies","expert","opinion","drug","discovery","vol"],"title":"Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies: Expert Opinion on Drug Discovery: Vol 13, No 10","year":2020}